Business & Regulation

From Carl June to Peter Marks to Kiran Mazumdar-Shaw; check out our thought provoking interviews with some of the biggest names in the pharma field.

Our latest news roundup reports on Roche’s US investment, a lawsuit against Vertex Pharmaceuticals, and more.

EMA reflection paper considers elimination of routine comparative efficacy studies for biosimilars.

Trump signs executive order on lowering drug prices and amends Medicare price negotiation for small molecule drugs.

Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded.

The political situation in the US and its impact on science and medicine is changing rapidly. Here’s a quick look at the latest developments.

Lore Gruenbaum discusses The Leukemia & Lymphoma Society, advances in blood cancers, and the role of nonprofits.

ADCs have shown their promise, but the next step is realizing their potential.

FDA to phase out mandatory animal testing with human-relevant methods for drug development

Donald Trump threatens “major tariff” on pharmaceuticals.